Eva Versteijne

2.6k citations

32 papers · 895 indexed · 1 hit paper · h-index 14

Oncology top 5%
Pulmonary and Respiratory Medicine top 5%
Surgery top 10%
Cancer Research top 10%
Radiology, Nuclear Medicine and Imaging top 10%

Co-authors: Geertjan van Tienhoven Casper H.J. van Eijck Olivier R. Busch Marc G. Besselink Johanna W. Wilmink Bas Groot Koerkamp Joost G. Daams C. Rasch
Topics: Pancreatic and Hepatic Oncology Research (16 papers)Advanced Radiotherapy Techniques (9 papers)Neuroendocrine Tumor Research Advances (6 papers)
Cited by: Oncology Radiation Pulmonary and Respiratory Medicine
Journals: Journal of Clinical Oncology Annals of Surgery International Journal of Radiation Oncology*Biology*Physics
Partner nations: Netherlands United Kingdom Italy

In The Last Decade

Eva Versteijne

29 papers receiving 887 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer

2018 349 citations Eva Versteijne, Marc G. Besselink et al. profile →

Peers

Countries citing papers authored by Eva Versteijne

Since Specialization

Citations

This map shows the geographic impact of Eva Versteijne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Versteijne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Versteijne more than expected).

Fields of papers citing papers by Eva Versteijne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Versteijne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Versteijne. The network helps show where Eva Versteijne may publish in the future.

Co-authorship network of co-authors of Eva Versteijne

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Versteijne. A scholar is included among the top collaborators of Eva Versteijne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Versteijne. Eva Versteijne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Routine Use of Single Visit Online Adaptive Cone Beam Computed Tomography Guided Sim-Free Palliative Radiation Therapy 2025 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown),Wilko F.A.R. Verbakel,(unknown),J. Visser,Eva Versteijne	1
2	Noninvasive Mechanical Ventilation Is a Promising Way to Improve Lung Cancer Radiation Therapy 2024 ·Advances in Radiation Oncology ·(unknown),Z. van Kesteren,Michael J. Parkes,Markus F. Stevens,Joost G. van den Aardweg,Edith Dieleman,Eva Versteijne,Geertjan van Tienhoven,Arjan Bel,Irma W.E.M. van Dijk	0
3	Impact of Short-Course Palliative Radiation Therapy on Pancreatic Cancer-Related Pain: Prospective Phase 2 Nonrandomized PAINPANC Trial 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown),(unknown),Mirjam A. G. Sprangers,Konstantinos Pateras,A. Bruynzeel,M. Jacobs,Johanna W. Wilmink,Marc G. Besselink,Johannes Crezee,Geertjan van Tienhoven,Eva Versteijne	5
4	Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort 2023 ·Frontiers in Oncology ·(unknown),Frank J. Lagerwaard,Susan van Dieren,Martijn R. Meijerink,Hans van Vliet,Marc G. Besselink,Geertjan van Tienhoven,Eva Versteijne,Ben J. Slotman,Johanna W. Wilmink,Geert Kazemier,A. Bruynzeel	1
5	The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer 2023 ·Journal of Cancer Research and Clinical Oncology ·(unknown),Thomas van Ee,(unknown),Arantza Fariña Sarasqueta,Johanna W. Wilmink,Eva Versteijne,Olivier R. Busch,Marc G. Besselink,Laura L. Meijer,Yvette van Kooyk,Reina E. Mebius,Geert Kazemier	0
6	OC-0100 Short course radiation improves pain from pancreatic cancer: A prospective phase II study (NTR5143) 2023 ·Radiotherapy and Oncology ·(unknown),(unknown),Johanna W. Wilmink,Mirjam A. G. Sprangers,M. Jacobs,A. Bruynzeel,Marc G. Besselink,(unknown),Geertjan van Tienhoven,Eva Versteijne	0
7	Same-day adaptive palliative radiotherapy without prior CT simulation: Early outcomes in the FAST-METS study 2023 ·Radiotherapy and Oncology ·(unknown),Eva Versteijne,Suresh Senan,(unknown),M. Admiraal,J. Visser,(unknown),(unknown),D. Hoffmans,Ben J. Slotman,Wilko F.A.R. Verbakel	38
8	Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design 2022 ·BMC Cancer ·(unknown),Marc G. Besselink,Casper H.J. van Eijck,Martijn Intven,Bas Groot Koerkamp,Geert Kazemier,Hanneke W.M. van Laarhoven,Martijn R. Meijerink,I. Quintus Molenaar,Joost J. Nuyttens,Rob van Os,Hjalmar C. van Santvoort,Geertjan van Tienhoven,Helena M. Verkooijen,Eva Versteijne,Johanna W. Wilmink,Frank J. Lagerwaard,A. Bruynzeel,(unknown)	4
9	Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy? 2022 ·Frontiers in Oncology ·Eva Versteijne,Ignace H. J. T. de Hingh,Marjolein Y.V. Homs,Martijn Intven,Joost M. Klaase,Hjalmar C. van Santvoort,Judith de Vos‐Geelen,Johanna W. Wilmink,Geertjan van Tienhoven	7
10	The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the PREOPANC randomized controlled trial 2022 ·European Journal of Surgical Oncology ·(unknown),Eva Versteijne,Bert A. Bonsing,J. Sven D. Mieog,Ignace H. J. T. de Hingh,Sebastiaan Festen,Gijs A. Patijn,Ronald M. van Dam,Erwin van der Harst,Jan H. Wijsman,Koop Bosscha,(unknown),Vincent E. de Meijer,Mike S.L. Liem,Olivier R. Busch,Marc G. Besselink,Geertjan van Tienhoven,Bas Groot Koerkamp,Casper H.J. van Eijck,Mustafa Suker	10
11	Improved Overall Survival in Pancreatic Cancer with Preoperative Chemoradiotherapy: Long-term Results of the PREOPANC Trial 2021 ·HPB ·Eva Versteijne,Jacob L. van Dam,Mustafa Suker,Quisette P. Janssen,(unknown),Marc G. Besselink,O.R. Busch,(unknown),Bas Groot Koerkamp,Ignace H. J. T. de Hingh,Sebastiaan Festen,Gijs A. Patijn,Judith de Vos‐Geelen,A. H. Zwinderman,C.J.A. Punt,Casper H.J. van Eijck,Geertjan van Tienhoven	3
12	Preoperative chemoradiotherapy to improve overall survival in pancreatic cancer: Long-term results of the multicenter randomized phase III PREOPANC trial. 2021 ·Journal of Clinical Oncology ·Casper H.J. van Eijck,Eva Versteijne,Mustafa Suker,(unknown),Marc G. Besselink,Olivier R. Busch,Bert A. Bonsing,Bas Groot Koerkamp,Ignace H. J. T. de Hingh,Sebastiaan Festen,Gijs A. Patijn,Judith de Vos‐Geelen,Aeilko H. Zwinderman,Cornelis J.A. Punt,Geertjan van Tienhoven,(unknown)	28
13	Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data 2020 ·Frontiers in Oncology ·Francesco Giovinazzo,Fiammetta Soggiu,Jin‐Young Jang,Eva Versteijne,Geertjan van Tienhoven,Casper H.J. van Eijck,Youngmin Han,Seong Ho Choi,Chang Moo Kang,Mark M. Zalupski,(unknown),Sarah Yentz,Scott Helton,J. Bart Rose,Chie Takishita,Yuichi Nagakawa,Mohammad Abu Hilal	12
14	Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial) 2020 ·Annals of Surgery ·(unknown),Mustafa Suker,Eva Versteijne,Bert A. Bonsing,J. Sven D. Mieog,Judith de Vos‐Geelen,Erwin van der Harst,Gijs A. Patijn,Ignace H. J. T. de Hingh,Sebastiaan Festen,Albert J. ten Tije,Olivier R. Busch,Marc G. Besselink,Geertjan van Tienhoven,Bas Groot Koerkamp,Casper H.J. van Eijck	28
15	Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer 2017 ·Strahlentherapie und Onkologie ·Eva Versteijne,E. Lens,Astrid van der Horst,Arjan Bel,J. Visser,Cornelis J.A. Punt,Mustafa Suker,Casper H.J. van Eijck,Geertjan van Tienhoven	7
16	Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study 2017 ·Radiation Oncology ·Eva Versteijne,Oliver J. Gurney‐Champion,Astrid van der Horst,E. Lens,M. Willemijn Kolff,Jeroen Buijsen,(unknown),Karen J. Neelis,C. Rasch,Jaap Stoker,Marcel van Herk,Arjan Bel,Geertjan van Tienhoven	18
17	Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study 2017 ·Acta Oncologica ·Oliver J. Gurney‐Champion,Eva Versteijne,Astrid van der Horst,E. Lens,Heidi Rütten,H.D. Heerkens,Gabriel Paardekooper,Maaike Berbée,C. Rasch,Jaap Stoker,Marc Engelbrecht,Marcel van Herk,Aart J. Nederveen,Remy Klaassen,Hanneke W.M. van Laarhoven,Geertjan van Tienhoven,Arjan Bel	20
18	Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment 2016 ·Diseases of the Esophagus ·Paul M. Jeene,Eva Versteijne,Mark I. van Berge Henegouwen,(unknown),Elisabeth D. Geijsen,Karin Müller,Hanneke W.M. van Laarhoven,Maarten C.C.M. Hulshof	8
19	Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation 2016 ·Acta Oncologica ·Paul M. Jeene,Eva Versteijne,Mark I. van Berge Henegouwen,(unknown),Elisabeth D. Geijsen,Hanneke W.M. van Laarhoven,Maarten C.C.M. Hulshof	18
20	Dosimetric Advantages of Midventilation Compared With Internal Target Volume for Radiation Therapy of Pancreatic Cancer 2015 ·International Journal of Radiation OncologyBiologyPhysics ·E. Lens,Astrid van der Horst,Eva Versteijne,Geertjan van Tienhoven,Arjan Bel	19

About Eva Versteijne

Eva Versteijne is a scholar working on Radiation, Oncology and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 895 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (16 papers), Advanced Radiotherapy Techniques (9 papers) and Neuroendocrine Tumor Research Advances (6 papers). The work is most often cited by research in Oncology (590 citations), Radiation (132 citations) and Pulmonary and Respiratory Medicine (465 citations). Eva Versteijne has collaborated with scholars based in Netherlands, United Kingdom and Italy. Frequent co-authors include Geertjan van Tienhoven, Casper H.J. van Eijck, Olivier R. Busch, Marc G. Besselink, Johanna W. Wilmink, Bas Groot Koerkamp, Joost G. Daams, C. Rasch, Jantien A. Vogel and Hanneke W.M. van Laarhoven. Their work appears in journals such as Journal of Clinical Oncology, Annals of Surgery and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact